Perioperativer Einsatz der Tranexamsäure in der Endoprothetik
Tóm tắt
Từ khóa
Tài liệu tham khảo
Thole C (2019) Qualitätsreport 2019. IQTiG, Berlin
WOMAN Trial Collaborators (2017) Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet 389(10084):2105–2116
Roberts I, Shakur H, Afolabi A et al (2011) The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH‑2 randomised controlled trial. Lancet. https://doi.org/10.1016/S0140-6736(11)60278-X
Massicotte L, Denault AY, Beaulieu D, Thibeault L, Hevesi Z, Roy A (2011) Aprotinin versus tranexamic acid during liver transplantation: impact on blood product requirements and survival. Transplantation 91:1273–1278
Coetzee MJ (2007) The use of topical crushed tranexamic acid tablets to control bleeding after dental surgery and from skin ulcers in haemophilia. Haemophilia 13:443–444
Draxler DF, Medcalf RL (2015) The fibrinolytic system-more than fibrinolysis? Transfus Med Rev 29:102–109
Petersen W, Bierke S, Hees T et al (2019) „Fast-Track-Konzepte“ in der Knieendoprothetik: Einsatz von Tranexamsäure und Technik der lokalen intraartikulären Anästhesie. Oper Orthop Traumatol 31:447–462
McCormack PL (2012) Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis. Drugs 72:585–617
Medizinprodukte BfAu (2014) Fachinformation Tranexamsäure
Roth PKL, Treskatsch S, Perka C (2017) Die perioperative Gabe von Tranexamsäure. Empfehlung der AE-Deutschen Gesellschaft für Endoprothetik, AE-Handlungsempfehlung
Alshryda S, Sarda P, Sukeik M, Nargol A, Blenkinsopp J, Mason JM (2011) Tranexamic acid in total knee replacement; a systematic review and meta-analysis. J Bone Joint Surg Br 93(12):1577–1585
Gombotz H, Rehak PH, Shander A, Hofmann A (2014) The second Austrian benchmark study for blood use in elective surgery: results and practice change. Transfusion 54:2646–2657
Sukeik M, Alshryda S, Haddad FS, Mason JM (2011) Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br 93:39–46
Huang F, Wu D, Ma G, Yin Z, Wang Q (2014) The use of tranexamic acid to reduce blood loss and transfusion in major orthopedic surgery: a meta-analysis. J Surg Res 186:318–327
Wei Z, Liu M (2015) The effectiveness and safety of tranexamic acid in total hip or knee arthroplasty: a meta-analysis of 2720 cases. Transfus Med 25:151–162
Fillingham YA, Ramkumar DB, Jevsevar DS et al (2018) The efficacy of tranexamic acid in total knee arthroplasty: a network meta-analysis. J Arthroplasty 33:3090–3098.e1
Nishida T, Kinoshita T, Yamakawa K (2017) Tranexamic acid and trauma-induced coagulopathy. J Intensive Care 5:5
Fillingham YA, Ramkumar DB, Jevsevar DS et al (2018) Tranexamic acid use in total joint arthroplasty: The clinical practice guidelines endorsed by the American Association of Hip and Knee Surgeons, American Society of Regional Anesthesia and Pain Medicine, American Academy of Orthopaedic Surgeons, Hip Society, and Knee Society. J Arthroplasty 33:3065–3069
Kearon C (2003) Natural history of venous thromboembolism. Circulation 107:I22–I30
Sabbag OD, Abdel MP, Amundson AW, Larson DR, Pagnano MW (2017) Tranexamic acid was safe in arthroplasty patients with a history of venous thromboembolism: a matched outcome study. J Arthroplasty 32:S246–S250
Fillingham YA, Ramkumar DB, Jevsevar DS et al (2018) The safety of tranexamic acid in total joint arthroplasty: a direct meta-analysis. J Arthroplasty 33:3070–3082.e1
Keyl C, Uhl R, Beyersdorf F et al (2011) High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement. Eur J Cardiothorac Surg 39:e114–e121
Lecker I, Wang DS, Whissell PD, Avramescu S, Mazer CD, Orser BA (2016) Tranexamic acid-associated seizures: causes and treatment. Ann Neurol 79:18–26
Chen Y, Chen Z, Cui S, Li Z, Yuan Z (2016) Topical versus systemic tranexamic acid after total knee and hip arthroplasty: a meta-analysis of randomized controlled trials. Medicine (Baltimore) 95(41):e4656
Nielsen CS, Jans O, Orsnes T, Foss NB, Troelsen A, Husted H (2016) Combined intra-articular and intravenous tranexamic acid reduces blood loss in total knee arthroplasty: a randomized, double-blind, placebo-controlled trial. J Bone Joint Surg Am 98:835–841
Calligaro KD, Veith FJ, Yuan JG, Gargiulo NJ, Dougherty MJ (2003) Intra-abdominal aortic graft infection: complete or partial graft preservation in patients at very high risk. J Vasc Surg 38:1199–1205
Yi Z, Bin S, Jing Y, Zongke Z, Pengde K, Fuxing P (2016) Tranexamic acid administration in primary total hip arthroplasty: a randomized controlled trial of intravenous combined with topical versus single-dose intravenous administration. J Bone Joint Surg Am 98:983–991
Fillingham YA, Kayupov E, Plummer DR, Moric M, Gerlinger TL, Della Valle CJ (2016) The James A. Rand Young investigator’s award: A randomized controlled trial of oral and intravenous tranexamic acid in total knee arthroplasty: the same efficacy at lower cost? J Arthroplasty 31:26–30
Maradit Kremers H, Larson DR, Crowson CS et al (2015) Prevalence of total hip and knee replacement in the United States. J Bone Joint Surg Am 97:1386–1397
Sehat KR, Evans R, Newman JH (2000) How much blood is really lost in total knee arthroplasty? Correct blood loss management should take hidden loss into account. Knee 7:151–155
Mohib Y, Rashid RH, Ali M, Zubairi AJ, Umer M (2015) Does tranexamic acid reduce blood transfusion following surgery for inter-trochanteric fracture? A randomized control trial. J Pak Med Assoc 65:S17–S20
Hochreiter J, Hejkrlik W, Emmanuel K, Hitzl W, Ortmaier R (2017) Blood loss and transfusion rate in short stem hip arthroplasty. A comparative study. Int Orthop 41:1347–1353
Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J (2008) Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res 466:1710–1715
Li Z‑J, Zhao M‑W, Zeng L (2018) Additional dose of intravenous tranexamic acid after primary total knee arthroplasty further reduces hidden blood loss. Chin Med J (Engl) 131:638–642